Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Problem pathogens (Pseudomonas aeruginosa and Acinetobacter).

J Chastre1, J L Trouillet

  • 1Service de Réanimation Médicale, H pital Bichat-Claude Bernard, Paris, France. jean.chastre@bch.ap-hop-paris.fr

Seminars in Respiratory Infections
|February 28, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Same author

Key considerations on nebulization of antimicrobial agents to mechanically ventilated patients.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Same author

Nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus treated with linezolid or vancomycin: A secondary economic analysis of resource use from a Spanish perspective.

Medicina intensiva·2016
Same author

Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: a call for international guidelines.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2016
Same author

Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015
Same author

Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2014
Same journal

TB vaccines at the turn of the century: insights into immunity to M. tuberculosis and modern approaches for prevention of an ancient disease.

Seminars in respiratory infections·2003
Same journal

Environmental infection control of tuberculosis.

Seminars in respiratory infections·2003
Same journal

Mycobacterium tuberculosis: the treatment of active disease.

Seminars in respiratory infections·2003
Same journal

Pediatric tuberculosis.

Seminars in respiratory infections·2003
Same journal

Clinical and radiographic features of HIV-related tuberculosis.

Seminars in respiratory infections·2003
Same journal

Treatment of latent tuberculosis infection.

Seminars in respiratory infections·2003
See all related articles

Preventing unnecessary antibiotic use is crucial for managing intensive care unit (ICU) patients at high risk for Pseudomonas and Acinetobacter pneumonia. Early diagnosis and targeted therapy improve outcomes for these severe infections.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Hospital-Acquired Infections

Background:

  • Intensive care unit (ICU) patients face increased risk of lower respiratory tract infections, particularly pneumonia, from Pseudomonas and Acinetobacter species.
  • Key risk factors include prolonged ICU stay, mechanical ventilation, and prior antibiotic exposure, with advanced age and comorbidities also contributing.
  • Nosocomial pneumonia caused by these gram-negative bacteria carries a high mortality rate, especially in ventilator-dependent patients.

Purpose of the Study:

  • To highlight the critical importance of preventing unnecessary antibiotic administration in ICU patients.
  • To emphasize the significant risks and poor prognosis associated with Pseudomonas and Acinetobacter pneumonia in the ICU.
  • To advocate for improved diagnostic strategies to avoid overtreatment.

Related Experiment Videos

Main Methods:

  • Review of risk factors associated with Pseudomonas and Acinetobacter colonization and pneumonia in the ICU setting.
  • Analysis of reported mortality rates for nosocomial pneumonia caused by these specific pathogens.
  • Discussion of current preferred therapeutic strategies, including combination antibiotic therapy.

Main Results:

  • Extended ICU care, prolonged mechanical ventilation, and prior antibiotic therapy are identified as the most significant risk factors.
  • Mortality rates for nosocomial pneumonia due to Pseudomonas and/or Acinetobacter spp. range from 30% to 75%, with higher rates in ventilator-dependent patients.
  • Bactericidal synergy is demonstrated for beta-lactam and aminoglycoside combinations against these pathogens.

Conclusions:

  • Avoiding unnecessary antibiotic therapy is the only preventable factor and should be a high priority in ICU patient management.
  • Combination therapy with a beta-lactam (e.g., piperacillin, ceftazidime) and an aminoglycoside is the preferred treatment approach.
  • Future research should focus on enhancing diagnostic accuracy to prevent unnecessary antibiotic use in non-infected ICU patients.